🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06196307
Recruiting Observational

Early Warning and Classification Model for Acute Non-traumatic Chest Pain

NCT06196307 · tracked via the Priya Life Science China tracker
Sponsor
Xiao-nan He
Phase
Observational
Started
2022-08-30
Last updated
2026-02-05

Condition(s) studied

Chest Pain

Investigational drug(s) / intervention(s)

Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization: Examination: Electrocardiogram、 imaging examination、 X-ray, CTA, bedside echocardiography. Laboratory test results of patients, including complete blood count, D-dimer, myocardial injury markers, sST2, MPO, and other indicators. History of cardiovascular and pulmonary vascular drug therapy: Antithrombotic therapy (type, measurement) , Anticoagulation therapy (type, metering), Other drug treatments (type, measurement)

Study summary

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 18 years 2. Symptom onset or worsening within 24 hours before presentation, with a chief complaint of acute chest pain meeting the broad definition of chest pain (2021 AHA) 3. Presentation to the emergency department, with a clinical diagnosis consistent with non-traumatic chest pain 4. Signed informed consent Exclusion Criteria: 1. traumatic chest pain 2. systemic pain caused by malignant tumors or rheumatic diseases involving the chest 3. Patients were lost to follow-up

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xiaonan He Beijing Chaoyang Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06196307 on ClinicalTrials.gov ↗ ← All trials in China